1. Home
  2. SPCE vs CDXS Comparison

SPCE vs CDXS Comparison

Compare SPCE & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virgin Galactic Holdings Inc.

SPCE

Virgin Galactic Holdings Inc.

HOLD

Current Price

$2.88

Market Cap

287.2M

ML Signal

HOLD

Logo Codexis Inc.

CDXS

Codexis Inc.

HOLD

Current Price

$2.33

Market Cap

256.3M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPCE
CDXS
Founded
2017
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Transportation Services
Major Chemicals
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
287.2M
256.3M
IPO Year
2017
2008

Fundamental Metrics

Financial Performance
Metric
SPCE
CDXS
Price
$2.88
$2.33
Analyst Decision
Hold
Analyst Count
5
0
Target Price
$3.06
N/A
AVG Volume (30 Days)
63.6M
825.4K
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
60.84
43.82
EPS
N/A
N/A
Revenue
$1,544,000.00
$138,590,000.00
Revenue This Year
$2,270.73
$7.73
Revenue Next Year
$880.03
$14.24
P/E Ratio
N/A
N/A
Revenue Growth
N/A
32.30
52 Week Low
$2.13
$0.96
52 Week High
$8.90
$3.87

Technical Indicators

Market Signals
Indicator
SPCE
CDXS
Relative Strength Index (RSI) 44.05 44.22
Support Level $2.63 $1.57
Resistance Level $3.01 $2.69
Average True Range (ATR) 0.56 0.16
MACD -0.24 -0.03
Stochastic Oscillator 11.49 26.60

Price Performance

Historical Comparison
SPCE
CDXS

About SPCE Virgin Galactic Holdings Inc.

Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.

About CDXS Codexis Inc.

Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.

Share on Social Networks: